Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 4/20 | 0.50 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.46 |
| ▸ | CETP | P11597 | 1/20 | 0.44 |
| ▸ | SELP | P16109 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2959758 | 0.97 | TLR4 (0.54) | TLR4CETPSELP | |
| SCHEMBL7532142 | 0.94 | TLR4 (0.56) | TLR4CETPSELP | |
| SCHEMBL2959757 | 0.90 | TLR4 (0.54) | TLR4CETPSELP | |
| SCHEMBL4185270 | 0.90 | LGALS8 (0.50) | TLR4LGALS8 | |
| SCHEMBL3393533 | 0.90 | LGALS8 (0.50) | TLR4LGALS8 | |
| SCHEMBL4181285 | 0.90 | LGALS8 (0.50) | TLR4LGALS8 | |
| SCHEMBL4199470 | 0.90 | LGALS8 (0.50) | TLR4LGALS8 | |
| SCHEMBL3388849 | 0.90 | LGALS8 (0.50) | TLR4LGALS8 | |
| SCHEMBL4185394 | 0.90 | LGALS8 (0.50) | TLR4LGALS8 | |
| SCHEMBL4193271 | 0.90 | TLR4 (0.49) | TLR4LGALS8SELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023205439-A2 | SKIN BARRIER PROTECTIVE DELIVERY SYSTEMS AND METHODS THEREOF | BOBO LABS INC. (US) | 2023-10-26 | — | — | WO | disclosed |
| US-20230024972-A1 | BAKUCHINOYL RETINOATE AND METHODS OF USE THEREOF | PHYTO TECH CORP D/B/A/ BLUE CALIFORNIA CO (US) | 2023-01-26 | — | — | US | disclosed |
| WO-2022266493-A1 | BAKUCHINOYL RETINOATE AND METHODS OF USE THEREOF | PHYTO TECH CORP D/B/A/ BLUE CALIFORNIA CO (US) | 2022-12-22 | — | — | WO | disclosed |
| US-20200261580-A1 | Photodynamic Therapy Method for Skin Disorders | DUSA PHARMACEUTICALS, INC. | 2020-08-20 | — | — | US | disclosed |
| EP-2379082-B1 | ACNE TREATMENT POWDER FOUNDATION | EI INC (US) | 2016-02-10 | — | — | EP | disclosed |
| US-9125919-B2 | Acne treatment powder foundation | EI LLC (US) | 2015-09-08 | — | — | US | disclosed |
| US-20150119369-A1 | Clear, Greaseless Compositions | CHEMSIL SILICONES INC (US) | 2015-04-30 | — | — | US | disclosed |
| US-8900607-B1 | Clear, greaseless skin-care compositions | CHEMSIL SILICONES, INC. (US) | 2014-12-02 | — | — | US | disclosed |
| US-8852615-B1 | Clear, greaseless skin-care compositions | CHEMSIL SILICONES, INC. (US) | 2014-10-07 | — | — | US | disclosed |
| US-20140018328-A1 | Clear, Greaseless Skin Care Compositions | CHEMSIL SILICONES, INC. (US) | 2014-01-16 | — | — | US | disclosed |
| WO-2001002028-A2 | PRE-FORMED, SHEET DEVICES SUITABLE FOR TOPICAL APPLICATION | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
| WO-2001001933-A2 | PRE-FORMED, SELF-ADHESIVE SHEET DEVICES SUITABLE FOR TOPICAL APPLICATION | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
| WO-2001001950-A1 | PRE-FORMED GEL SHEET | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
| WO-2001002477-A1 | PRE-FORMED, SELF-ADHESIVE SHEETS SUITABLE FOR TOPICAL APPLICATION | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
| WO-2001001951-A1 | SHEET-LIKE DEVICES | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
| WO-2001001952-A1 | DEVICES | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
| US-6153208-A | A WATER INSOLUBLE SUBSTRATE HAVING A SEPARATE CLEANSING AND CONDITIONING PORTIONS WITH DIFFERENT WET EXTENSIBLE, A LATHERING SURFACTANT; DRY WASHCLOTH | THE PROCTER & GAMBLE COMPANY (US) | 2000-11-28 | — | — | US | disclosed |
| EP-1011630-A1 | CLEANSING AND CONDITIONING ARTICLE FOR SKIN OR HAIR | THE PROCTER & GAMBLE COMPANY (US) | 2000-06-28 | — | — | EP | disclosed |
| WO-1999055303-A1 | CLEANSING ARTICLES FOR SKIN AND/OR HAIR WHICH ALSO DEPOSITS SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 1999-11-04 | — | — | WO | disclosed |
| WO-1999013861-A1 | CLEANSING AND CONDITIONING ARTICLE FOR SKIN OR HAIR | THE PROCTER & GAMBLE COMPANY (US) | 1999-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230024972-A1 | BAKUCHINOYL RETINOATE AND METHODS OF USE THEREOF | RBP4, RARA, RARB | TLR4 3949/4885LGALS8 1485/4885CETP 1459/4885 |
| US-20200261580-A1 | Photodynamic Therapy Method for Skin Disorders | ALAD, KRT18, DHPS | TLR4 3539/4885LGALS8 4249/4885CETP 1685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.